In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Kallyope raises $44mm in Series A round

Executive Summary

Newly launched New York biotech Kallyope Inc. (focused on gut-brain axis circuits) raised $44mm in a Series A round from eight investors including Lux Capital, Polaris Partners, The Column Group, Illumina Inc., Alexandria Venture Investments, and Tony Evnin, PhD, a partner at Venrock and a board member.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies